Chinese yeast factory boosts cancer drug production speed 1,000 times
Researchers at Zhejiang University, in collaboration with teams from the University of New Brunswick and Westlake University, have engineered brewer's yeast to produce catharanthine, a direct precursor to the cancer drug vinblastine. This breakthrough significantly increases production efficiency, yielding nearly 1,000 times more catharanthine per liter compared to previous global figures.

Briefing Summary
AI-generatedResearchers at Zhejiang University, in collaboration with teams from the University of New Brunswick and Westlake University, have engineered brewer's yeast to produce catharanthine, a direct precursor to the cancer drug vinblastine. This breakthrough significantly increases production efficiency, yielding nearly 1,000 times more catharanthine per liter compared to previous global figures. Vinblastine has historically been extracted from the Madagascar periwinkle plant, a process that is extremely inefficient, requiring two tonnes of leaves for just one gram of the drug. This scarcity has made vinblastine costly and its supply unreliable for decades. The new yeast-based method offers a potential solution to these long-standing production challenges.
Article analysis
Model · rule-basedKey claims
4 extractedThe extreme scarcity of vinblastine makes it costly and its supply unreliable.
Vinblastine is currently sourced from the Madagascar periwinkle plant, requiring 2 tonnes of dried leaves for 1 gram of the drug.
The engineered yeast produces catharanthine at a rate of 164.9 milligrams per litre, nearly 1,000 times higher than previous global figures.
A research team at Zhejiang University engineered brewer's yeast to produce catharanthine, a precursor to the cancer drug vinblastine.